Posterior Fossa Decompression (for symptomatic Chiari II)
Treatment for Neural tube defects
Typical Dosage: N/A (surgical procedure)
Effectiveness
70%
Safety Score
55%
Clinical Trials
50
Participants
5K
Comparative Safety Scale(Higher is safer)
Cyanide☠️
Meth💀
Cigarettes🚬
Chemo☢️
Alcohol🍺
Morphine💊
Antibiotics💉
Tylenol💊
Exercise🏃
Water💧
55
DangerousModerateSafe
Treatment Details
Dosage Range
N/A (surgical procedure)
Time to Effect
Days to weeks
Treatment Duration
Single surgical intervention
Evidence Quality
MODERATENumber Needed to Treat (NNT)
4(Treat 4 patients to see 1 additional successful outcome)
Number Needed to Harm (NNH)
15(Treat 15 patients to see 1 additional serious adverse event)
Confidence Score
80%confidence in effectiveness data
Health Economics
Annual Cost of Care
Drug Cost:$0
Monitoring:$750
Side Effect Mgmt:$3,000
Total Annual:$53,750
Cost-Effectiveness Analysis
Cost-Effectiveness Rating
MODERATEQALYs Gained
0.7
Outcome-Based Costs
Cost per Responder
$71,666.67
Posterior Fossa Decompression (for symptomatic Chiari II) Outcomes
for Neural tube defects
Efficacy Outcomes
Overall Effectiveness
+70%
Response Rate
+75%
Common Side Effects
CSF leak
+7%
Surgical site infection
+4%
Persistent symptoms
+25%
Meningitis
+2%
Sources:
WARNING: LIMITED TRIALS AVAILABLE
You can search for trials, but you probably can't join any because the 1% Treaty hasn't passed yet. Most trials are severely limited by lack of funding and bureaucratic barriers. Help change this!
Active Clinical Trials
No active trials currently recruiting for this treatment
No active trials found in ClinicalTrials.gov